FDA Clearance Tracker · P140002-S002
MISAGO PERIPHERAL SELF-EXPANDING STENT SYSTEM
Last checked: Nov 20, 2026Latest source record: Mar 8, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Mar 8, 2017
Approved
Time to decision
306 days
Received May 6, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P140002-S002
- Device name
- MISAGO PERIPHERAL SELF-EXPANDING STENT SYSTEM
- Applicant
- Terumo Medical Corporation
- Applicant location
- Hatagaya
- Received
- May 6, 2016
- Decided
- Mar 8, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P140002
Device type
- Device type
- STENT, SUPERFICIAL FEMORAL ARTERY (NIP)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for changes to the device delivery system, associated labeling changes, new manufacturing equipment and new material suppliers.
Source documents
Other decisions for Terumo Medical Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MISAGO(TM) RX Self-expanding Peripheral StentPMA supplement
P140002-S032 · Decided Jul 16, 2026 · 199 days after receipt · Panel Track
Device type: STENT, ILIAC (NIO) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.